Tristel Share Discussion Threads

[mach100] 20/10/2017 10:59

I think today's fall which I didn't expect is due to investors takinga dim view of the flattering currency windfall in yesterday's update. I think the bigger picture belies that and hopefully France, America, Japan and India will unleash some new hunting ground for income.

[mach100] 19/10/2017 22:41

There was quite a bit of interest aroused by the mobile company which TSTL has a stake in. The chairman of TSTL also has a personal stake in it. It will certainly be useful for remote diagnostics in the developing world and elsewhere.

As glaws has pointed out above there will be moves into Japan and India. Given their populations it might allay fears about market saturation in my opinion.

At constant currency growth would have been about 10% There are no plans to do hedging of currency. Liz pointed out it would have been detrimental to this year's results if hedged. It is also not an area of TSTL expertise.

Re-submission to the EPA will definitely happen by the new November date as that is within the company's control. I asked about the danger of slippage to the deadline in May given what happened to the share price when an initial delay was announced. Paul answered fairly that "you are damned if you do and damned if you don't"

Cash at bank has improved since today's report.

A SCRIP dividend has never been considered. In discussions afterwards an investor said the company was probably too small for SCRIPs.
Strategically Paul was keen to emphasise that TSTL was not all about North America. This was underlined by today's results.

The company are on track for sales of £22.8m to £26 million in 2019.

The question that never dies (TQTND) came up again about Tristel's use in dental surgeries for which it is mostly unsuitable. The company has some success with its disinfectant with a leading Vetinary group from what I could gather.

Piedro I will ask you for questions in advance next time I am attending as I don't recall either of your questions above being covered.

[piedro] 19/10/2017 22:07

A couple of questions for anyone who went to the presentions:

- any comments on the Anistel and Crystel drop in sales?
- ROW surfaces - till when is the bad packaging excuse still valid {ROW surfaces revenue}?

TIA.

[piedro] 19/10/2017 16:41

New motto:

pp.11
- Tristel :the only manually applied high-level disinfectant worldwide

[glaws2] 19/10/2017 16:38

A comment (from the presentation) about the "low" underlying sales growth of 7%.

They maintain their published target of increasing revenues by 10-15% per annum and confirmed that they are currently on course to achieve this in the current financial year. This will be achieved in a number of ways:

1. organic growth
2. buying distributors (as they did in Australia). Hong Kong likely to be next.
3. They are looking at setting subsidaries in both Japan & India
4. Continual expansion of approvals (24 products in 19 countries approved last year)
After 3 yers of trying finally got approval in France for Duo
5. Mobile applications

[zimbtrader] 19/10/2017 16:26

Mach, pass on my best wishes to your gut and may it continue to correctly predict future movements. ;-) I wish I could say my exit was meticulously timed and planned. Circumstances - and timing - simply worked in my favour. Nice mention of my old home town bowlers. I wish the current crop were as good as the chicken farmer who "flippin' murdered" England all those years ago. I once (and only once) faced Eddo Brandes - said chicken farmer - in the nets at school. Man, he was VERY, VERY quick!

Back to more serious matters.. Peidro - VERY good points raised, indeed! Did anyone manage to make it onto the investors presentations? I wasn't able to due to work and nothing (yet) available on their website ( ).

[piedro] 19/10/2017 16:25

Glaws2,

Thank you.

Just got my copy of the presentation by writing to ... Tristel@WalbrookPR

[glaws2] 19/10/2017 16:22

Piedro

Revenue breakdown by country :(£k)

UK 10,675
Germany 3,260 (includes sales to Poland, Austria & Switzerland)
Australia 1,991
NZ 604
Hong Kong 588
China 524
Russia 61
Distributors (in 35 countries) 2,570

[piedro] 19/10/2017 11:48

FWIW,



- looking better but the first 6 months [H1] of the year usually show a better margin

[piedro] 19/10/2017 11:22

WOW !!
I was disappointed by their presentation of the results
- we knew that revenues were on the up and up
- we knew there would be no special dividend

but, but, ....
- I'm confused by their geographical revenue analysis
- the CEO breaks it down by UK, Europe and ROW
- the Segment report by UK, Germany and ROW
- is Germany, Europe?
- surely Australia deserves a mention

Perhaps as Zimbtrader suggests, it will all be explained later today

I do like consistency

[zimbtrader] 19/10/2017 10:23

No real surprises (good or bad) in these results. The last trading update had pretty much telegraphed revenue and profit figures. What I was pleased by was the lack of negative comments contained within but I'd have liked more detail pertaining to the delays with the EPA. Perhaps more may come via the presentations later today...

I'm not surprised at there being no special divi. I personally see it as a better use of investors money as a "war chest" to fund US and Canadian expansion (assuming that materialises).

Yes, 10-15% targets for the next 2 years are ambitious but Tristel seem well placed to achieve these and, perhaps, may be on the low side if and when US approval comes...

Mach100, was it you who posted earlier this year that we'd see 300p by end of this year? I have to admit I did laugh at that post back then but that changed to "laughing all the way to the bank" at 306.5 when I sold half my holding! I sincerely hope your latest prediction is also realised as I did buy back in between 280 and 285p!

[mach100] 19/10/2017 10:09

Hi Hydrus. What price did you get for your sale? I think there is more to come here personally. I will reinvest the divi in December back into these.

[hydrus] 19/10/2017 09:52

Underlying sales growth of 7% - that suggests that the large increase in profits this year will be hard to replicate going forward. The company is on a very high rating and their foray into the states is not without risk and the business there will take considerable time to grow in any case. I still hold, albeit with profits taken now.

[mach100] 19/10/2017 09:30

Great results. I am surprised by the muted market reaction though I suspect on further consideration of these they will go above 300p. I can only think the lack of a special divi has weighed on investors. I was expecting one myself but as others have pointed out here they will use the money for the US etc. I would like to average up myself. I expected these to be 300p on announcing sales in the US. I now expect these to be 360p at least by May. Well done to the team!

[melton john] 19/10/2017 07:45

Brilliant results inho. Stockopedia gives estimated eps for 2018 as 8.07p. They have achieved that this year with a boost from the take over of their Aussie distributor. Target is to achieve 10-15% growth over next 2 years and by then US approvals if successful will change the game dramatically. It can be seen from Piedro's posts that we are exhibiting in other markets as well so the future looks rosy as far as I can see.

[piedro] 18/10/2017 13:50

Tristel Global‏ @TristelGlobal
Schnapp dir die Keime! Better. Safer. Faster.
Smarter. #BZH #hygiene #tristelschnapper

[piedro] 18/10/2017 13:43

Tristel Global‏ @TristelGlobal
Tristel Duo für Ultraschall, der einzige validierte
High-Level-Desinfektionsschaum. Besuchen Sie
uns an Stand 3 #hygiene #ultraschall #BZH
Translated from German
Tristel duo for ultrasound, the only validated high
level disinfectant foam. Visit us at stand 3 #hygiene #ultraschall #BZH

[piedro] 16/10/2017 12:03

3rd eye,
FWIW - your chart ...



"Not cheap though but may be one to take a look at."

- the one in the header looks good enough ... and without the tea-leaves

AIMHO.

[3rd eye] 16/10/2017 10:39

TSTL Tristel PLC report on thursday. Last trading Update 19/7/2017 showed....."Both turnover and pre-tax profit are ahead of market expectations".

As far as I can see no Broker as upgraded since that date. Not cheap though but may be one to take a look at.

Chart.........

[piedro] 14/10/2017 23:18

Something to think about ...

Questions and Answers related to the United Kingdom's
withdrawal from the European Union with regard to the medicinal
products for human and veterinary use within the framework of
the Centralised Procedure


... or not?

[piedro] 09/10/2017 16:40

Tristel Global‏ @TristelGlobal
Team @ESCRSofficial - Stand P1122 - Find out what
Tristel Duo can achieve in 30 seconds.
#ophthalmology #disinfection #ESCRS2017

[piedro] 09/10/2017 11:16

Tristel Global‏ @TristelGlobal
Team @ceorlhns2017 - Stand 16 for Trio, the complete
solution for high-level disinfection of non-lumened
medical devices! #ceorlhns2017

[piedro] 07/10/2017 21:48

Tristel Global
4 October at 03:17 ·
We are on the road again this week, meaning plenty of opportunities to speak to our knowledgeable team. Firstly, we will be at the World Federation for Hospital Sterilisation Sciences 2017 in Bonn, from 4th to the 7th of October. Come to stand D5 and ask about our products that provide bacteria-free, endotoxin free rinse water for AER's.
Second, we can be found at the 4th Congress of European ORL-HNS in Barcelona from the 7th to the 11th of October. Visit Stand 16 to find out about the Tristel Trio Wipes System, the complete solution for the high-level disinfection of non-lumened medical devices.
Finally, we will be exhibiting at the XXXV Congress of The European Society of Cataract and Refractive Surgeons in Lisbon from the 7th to the 11th of October. Visit Stand P1122 to find out what Tristel Duo can achieve in 30 seconds.